DUOXA2 | Dual oxidase maturation factor 2 | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
GPR110 | G protein-coupled receptor 110 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
SPP1 | Secreted phosphoprotein 1 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
ABCB5 | ATP-binding cassette, sub-family B (MDR/TAP), member 5 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
AC037459.4 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000428700} | Predicted intracellular proteins
| | | | | Tissue enhanced |
ADAMTS14 | ADAM metallopeptidase with thrombospondin type 1 motif, 14 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS16 | ADAM metallopeptidase with thrombospondin type 1 motif, 16 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
ADCYAP1 | Adenylate cyclase activating polypeptide 1 (pituitary) | Predicted secreted proteins
| | | | | Tissue enhanced |
AKR1B15 | Aldo-keto reductase family 1, member B15 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANXA13 | Annexin A13 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
B3GALT2 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
BDKRB1 | Bradykinin receptor B1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
C6orf141 | Chromosome 6 open reading frame 141 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C9orf92 | Chromosome 9 open reading frame 92 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CA9 | Carbonic anhydrase IX | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CASR | Calcium-sensing receptor | Disease related genes FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CATSPERB | Catsper channel auxiliary subunit beta | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CCL20 | Chemokine (C-C motif) ligand 20 | Predicted secreted proteins
| | | | | Tissue enhanced |
CFTR | Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CHRM2 | Cholinergic receptor, muscarinic 2 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CILP | Cartilage intermediate layer protein, nucleotide pyrophosphohydrolase | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
CILP2 | Cartilage intermediate layer protein 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
CLEC3A | C-type lectin domain family 3, member A | Predicted secreted proteins
| | | | | Tissue enhanced |
CNTNAP5 | Contactin associated protein-like 5 | Predicted membrane proteins
| | | | | Tissue enhanced |
COL10A1 | Collagen, type X, alpha 1 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
COL3A1 | Collagen, type III, alpha 1 | Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
COLEC11 | Collectin sub-family member 11 | Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
COMP | Cartilage oligomeric matrix protein | Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CPA3 | Carboxypeptidase A3 (mast cell) | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CPXM1 | Carboxypeptidase X (M14 family), member 1 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
CRLF2 | Cytokine receptor-like factor 2 | Cancer-related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CSMD2 | CUB and Sushi multiple domains 2 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CTHRC1 | Collagen triple helix repeat containing 1 | Disease related genes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CXCL6 | Chemokine (C-X-C motif) ligand 6 | Predicted secreted proteins
| | | | | Tissue enhanced |
CYP4F11 | Cytochrome P450, family 4, subfamily F, polypeptide 11 | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DCDC1 | Doublecortin domain containing 1 | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
DEPDC1B | DEP domain containing 1B | Predicted intracellular proteins
| | | | | Tissue enhanced |
DUOX2 | Dual oxidase 2 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
F2RL2 | Coagulation factor II (thrombin) receptor-like 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
FAM150A | Family with sequence similarity 150, member A | Predicted secreted proteins
| | | | | Tissue enhanced |
FAM180A | Family with sequence similarity 180, member A | Predicted secreted proteins
| | | | | Tissue enhanced |
FGF5 | Fibroblast growth factor 5 | Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
FGF7 | Fibroblast growth factor 7 | Cancer-related genes Predicted intracellular proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
FNDC1 | Fibronectin type III domain containing 1 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FOSL1 | FOS-like antigen 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
FOXL1 | Forkhead box L1 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
FXYD2 | FXYD domain containing ion transport regulator 2 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GEM | GTP binding protein overexpressed in skeletal muscle | Predicted intracellular proteins
| | | | | Tissue enhanced |
GLP2R | Glucagon-like peptide 2 receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GPBAR1 | G protein-coupled bile acid receptor 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |